Suppression of ventricular arrhythmias by propafenone, a new antiarrhythmic agent, during acute myocardial infarction in the conscious dog. A comparative study with lidocaine.
D000818:Animals; D001157:Arterial Occlusive Diseases / Q000150:complications; D003327:Coronary Disease / Q000150:complications; D003864:Depression, Chemical; D003971:Diastole / Q000187:drug effects; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D007275:Injections, Intravenous; D008012:Lidocaine / Q000627:therapeutic use*; D008297:Male; D009203:Myocardial Infarction / Q000209:etiology* / Q000473:pathology; D011405:Propafenone; D011427:Propiophenones / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D012849:Sinoatrial Node / Q000502:physiology; D013610:Tachycardia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
D011427:Propiophenones; D011405:Propafenone; D008012:Lidocaine